Combined aclidinium bromide and long-acting beta2-agonist for COPD

9Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy and safety of combined aclidinium bromide and long-acting beta2-agonists in stable COPD.

Cite

CITATION STYLE

APA

Ni, H., Moe, S., Soe, Z., Myint, K. T., & Viswanathan, K. N. (2015). Combined aclidinium bromide and long-acting beta2-agonist for COPD. Cochrane Database of Systematic Reviews, 2015(3). https://doi.org/10.1002/14651858.CD011594

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free